What is Lila Sciences?
Founded in 2023 and headquartered in Cambridge, Massachusetts, Lila Sciences is at the forefront of scientific innovation, developing the world's first scientific superintelligence platform. Incubated within Flagship Pioneering, the company's proprietary AI Science Factory (AISF) integrates advanced generative AI with autonomous laboratory infrastructure. This powerful combination enables the design, execution, observation, and iteration of scientific experiments across life sciences, chemistry, and materials science at an unprecedented scale and speed. Lila Sciences has already demonstrated remarkable early results, including the discovery of novel antibodies, genetic medicine constructs, green hydrogen catalysts, and advanced carbon capture materials, positioning it as a key player in the future of scientific research and development.
How much funding has Lila Sciences raised?
Lila Sciences has raised a total of $435M across 2 funding rounds:
Angel/Seed
$200M
Series A
$235M
Angel/Seed (2025): $200M with participation from March Capital, Flagship Pioneering, Ark Venture Fund, General Catalyst, Modi Ventures, Blue Horizon Advisors, and Altitude Life Science Ventures
Series A (2025): $235M led by Braidwell and Collective Global
Key Investors in Lila Sciences
Braidwell
Braidwell provides flexible capital and partnership to companies transforming human health across all stages and markets, focusing on public, private, and structured capital. They aim to support innovation in the health sector.
Collective Global
Collective Global is an investment collective formed by leading global allocators, partnering with venture managers to enhance investment in venture and growth stages. They focus on strategic investment solutions for sophisticated clients.
March Capital
March Capital is a growth-stage venture firm specializing in enterprise technology, aiming to scale companies into global platforms. They focus on large market opportunities and category leadership.
What's next for Lila Sciences?
With its recent major enterprise-level funding and a significant strategic investment, Lila Sciences is poised for accelerated growth and expansion into key global markets such as San Francisco and London. The substantial capital infusion will likely fuel the further development and scaling of its AI Science Factory (AISF) platform, enabling more ambitious research initiatives and faster discovery cycles. The company's strategic focus on integrating AI with laboratory automation suggests a trajectory aimed at revolutionizing R&D processes across multiple scientific disciplines, potentially leading to groundbreaking advancements and market leadership in AI-driven scientific discovery.
See full Lila Sciences company page
